Rate of control of LDL cholesterol and incident hypertension requiring antihypertensive treatment in hypercholesterolemic subjects in daily clinical practice

References

• Ferdinand KC, Kleinpeter MA. Management of hypertension and dyslipidemia. Curr Hypert Rep. 2006;8:489–96.
   PubMed Web of Science ®Google Scholar
• Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011; 104:109–24.
   PubMed Web of Science ®Google Scholar
• Martínez-González J, Badimon L. Influence of statin use on endothelial function: from bench to clinics. Curr Pharm Des. 2007;13:1771–86.
   PubMedGoogle Scholar
• Briasoulis A, Agarwal V, Valachis A, Messerli FH. The BP lowering antihypertensive effects of statins: a meta-analysis of prospective controlled studies. J Clin Hypertens. 2013;15:310–20.
   Web of Science ®Google Scholar
• Strazzullo P, Kerry SM, Barbato A, Versiero M, D’Elia L, Cappuccio FP. Do statins reduce blood pressure? A meta-analysis of randomized, controlled trials. Hypertension. 2007;49:792–8.
   PubMed Web of Science ®Google Scholar
• Prandin MG, Cicero AF, Dormi A, Cicero AF, Kuria F, Dormi A, et al. Prospective evaluation of the effect of statins on blood pressure control in hypertensive patients in clinical practice. Nutr Metab Cardiovasc Dis. 2010;20:512–18.
   PubMedGoogle Scholar
• Correa V Jr, Gus M, Fuchs FD. Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?. Expert Rev Cardiovasc Ther. 2010;8:775–9.
   PubMedGoogle Scholar
• Mancia G, Crepaldi G, Gallus G, Parati G, Veglia F, Bilo G, et al. Long-term statin administration and ambulatory blood pressure in the mild hypertensive and hypercholesterolemic patients: the PHYLLIS study. J Hypertens. 2002;20:S4
   Google Scholar
• Mancia G, Parati G, Revera M, Bilo G, Giuliano A, Veglia F, et al. Statins, antihypertensive treatment, and blood pressure control in clinic and over 24 hours: evidence from PHYLLIS randomised double blind trial. BMJ. 2010;340:c1197.
   PubMedGoogle Scholar
• Freitas MPD, de Loyola Filho AI, Lima-Costa MF. Dyslipidemia and the risk of incident hypertension in a population of community-dwelling Brazilian elderly: the Bambuí cohort study of aging. Cad Saude Publica. 2011;27:351–9.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Nyyssonen K, Lakka TA, Laukkanen JA, Salonen JT. Dyslipidaemia as a predictor of hypertension in middle-aged men. Eur Heart J. 2008;29:2561–8.
   PubMed Web of Science ®Google Scholar
• Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A. Adherence to statin treatment and health outcomes among newly treated patients: results from an administrative database analysis. Clin Ther. 2012;34:190–9.
   PubMed Web of Science ®Google Scholar
• Shalev V, Chodick G, Silber H, Kokia E, Jan J, Heymann AD. Continuation of statin treatment and all-cause mortality: a population-based cohort study. Arch Intern Med. 2009;169:260–8.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.; Management of Arterial Hypertension of the European Society Of Hypertension; European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
   PubMed Web of Science ®Google Scholar
• Sun Z, Zheng L, Detrano R, Zhang X, Xu C, Li J, et al. Incidence and predictors of hypertension among rural Chinese adults: results from Liaoning province. Ann Fam Med. 2010;8:19–24.
   PubMed Web of Science ®Google Scholar
• Marubini E, Valsecchi MG, Emmerson M. Analysing survival data from clinical trials and observational studies. New York: Wiley; 1995. p. 103–59.
   Google Scholar
• Borghi C, Dormi A, Veronesi M, Sangiorgi Z, Gaddi A; Brisighella Heart Study Working Party. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J. 2004;148:285–92.
   PubMed Web of Science ®Google Scholar
• Strehlow K, Wassmann S, Böhm M, Nickenig G. Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med. 2000;32: 386–9.
   PubMed Web of Science ®Google Scholar
• Nickenig G, Wassmann S, Böhm M. Regulation of the angiotensin AT1 receptor by hypercholesterolaemia. Diabetes Obes Metab. 2000; 2:223–8.
   PubMedGoogle Scholar
• Murakami K, Uehara Y, Abe S, Inoue Y, Ideishi M, Saku K, et al. Positive correlation between chymase-like angiotensin II-forming activity in mononuclear cells and serum cholesterol level. J Cardiol. 2007;50: 291–8.
   PubMedGoogle Scholar
• Niebauer J, Tsao PS, Lin PS, Pratt RE, Cooke JP. Cholesterol-induced upregulation of angiotensin II and its effects on monocyte-endothelial interaction and superoxide production. Vasc Med. 2001;6:133–8.
   PubMedGoogle Scholar
• van der Harst P, Wagenaar LJ, Buikema H, Voors AA, Plokker HW, Morshuis WJ, et al. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. Am J Cardiol. 2005;96:1361–4.
   PubMed Web of Science ®Google Scholar
• Nickenig G, Bäumer AT, Temur Y, Kebben D, Jockenhövel F, Böhm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation. 1999;100:2131–4.
   PubMed Web of Science ®Google Scholar
• Borghi C, Veronesi M, Cosentino E, Cicero AF, Kuria F, Dormi A, et al. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure. J Hypertens. 2007;25:2051–7.
   PubMed Web of Science ®Google Scholar
• Mihos CG, Salas MJ, Santana O. The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in cardiovascular disease: a comprehensive review. Cardiol Rev. 2010;18:298–304.
   PubMed Web of Science ®Google Scholar
• Borghi C. Interactions between hypercholesterolemia and hypertension: implications for therapy. Curr Opin Nephrol Hypertens. 2002;11: 489–96.
   PubMed Web of Science ®Google Scholar
• Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45–50.
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Brock DB, Harris T, Havlik RJ, Chrischilles EA, Ostfeld AM, et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med. 1995;155:1855–60.
   PubMedGoogle Scholar